Antibiotic potentiator OTX001
By potentiating existing antibiotics we can potentially offer clinicians many more treatment options when treating resistant infections.
This has the potential to be a “first in class” drug. At the used concentration our drug is not active by itself limiting resistance development.
- Antimicrobial compounds
- Alternative antimicrobials
Venture Capital consortium and/or major pharmaceutical company
Omnicin Therapeutics, is an early stage pharmaceutical company, developing potentiators for existing antibiotics.